Maze Therapeutics, Inc.
Maze Therapeutics, Inc.（MAZE）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
maze · 股价预测 · 6 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 6 位华尔街分析师
Buy
6 位分析师
共识
评级分布
12 个月目标价
High
$97.00
Consensus
$63.25
+168.2% upside
Low
$46.00
Median: $55 · Last Close: $23.58
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$63.25
168.2% upside
High Target
$97
311.4%
Low Target
$46
95.1%
Current Price
$23.58
as of today
Based on analyst price targets, the MAZE stock price prediction for the next 12 months ranges from $46 to $97. The consensus MAZE price forecast of $63.25 implies 168.2% upside from the current price of $23.58.
短期股价预测
Bear算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $22.82 | ↓ 3.22% |
1-day model range: $22.68–$22.96. Peak: $22.96 (-3.22%).
长期股价预测
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · MAZE · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-04-14 | Truist Securities | Maintains | Buy→Buy |
| 2026-03-31 | JP Morgan | Maintains | Overweight→Overweight |
| 2026-03-25 | BTIG | Maintains | Buy→Buy |
| 2026-03-25 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-16 | Wedbush | Maintains | Outperform→Outperform |
| 2026-03-09 | BTIG | Maintains | Buy→Buy |
| 2026-03-04 | Guggenheim | Maintains | Buy→Buy |
| 2026-01-16 | BTIG | Maintains | Buy→Buy |
| 2025-12-03 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-11-07 | Wedbush | Maintains | Outperform→Outperform |
Wall Street analysts have recently issued updated ratings on Maze Therapeutics, Inc. (MAZE) stock. Of the recent 17 rating actions, 0 were upgrades and 0 were downgrades. 6 analysts currently cover MAZE.
分析师推荐趋势
MAZE analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 6 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$20M
↑ 87.4% YoY
Revenue Next Year
$14M
↓ 30.5% YoY
EPS This Year
$-2.75
EPS Next Year
$-3.22
↑ 17.1% YoY
EPS ForecastReported vs Estimated
Analysts forecast MAZE EPS of $-2.75 for the current fiscal year, based on estimates from 7 analysts. The MAZE revenue forecast is $20M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
MAZE 股价预测由两类独立数据源支撑：来自 6 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。MAZE 的共识目标价为 $63.25（+168.2% 上行空间），分析师共识为 Buy。
MAZE 的短期预测（明日）为 $22.82（-3.22%）。
Maze Therapeutics, Inc. 在 NASDAQ 上市，代码 MAZE。MAZE 在 2027 年的整体展望偏积极，在覆盖分析师中约 100% 对应 Buy 共识。
常见问题
MAZE 预测 · 8 个问题根据 6 位华尔街分析师，MAZE 的 12 个月平均目标价为 $63.25，最高 $97.00、最低 $46.00。若有图表，中位目标价可在上方查看。相对当前价 $23.58，隐含约 +168.2% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.